MedPath

Study for apoptosis inhibitor of macrophage (Free AIM) for the prediction of hepatocellular carcinoma.

Not Applicable
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000030348
Lead Sponsor
The University of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
74
Inclusion Criteria

Not provided

Exclusion Criteria

none

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of plasma concentration of Free AIM for hepatocellular carcinoma
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath